Katy Miller

KATY MILLER is the US franchise head for lung cancer at AstraZeneca Oncology, overseeing US commercial activities with the goal of improving outcomes for lung cancer patients. She has held various leadership roles within sales, marketing, insights, and finance, with a primary focus in lung cancer. Miller’s professional experience has spanned across oncology, immunology, ophthalmology and other specialty disease areas, and across pipeline, pre-launch, launch, and mature indications, including roles at Human Genome Sciences and Genentech prior to joining AstraZeneca in 2012. Miller holds an MBA from Stanford University, a CFA charter, and a BA from the University of Pennsylvania.